<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

School of Medicine News and Stories

Cancer

Education    Community    Cancer    Student and Alumni

CU Medical Student Honors ‘1999’ Skier Robb Gaffney on Skis and in Medicine

In 1995, Robb Gaffney left behind the life of a full-time dirtbag skier to attend the University of Colorado School of Medicine — or that’s how his brother Scott Gaffney puts it in “1999,” a ski film turned cult classic that Scott recorded on 16mm film as a tribute to one of the best winters in ski history. 


Author Kara Mason | Publish Date November 29, 2023
Full Story

Education    Community    Students    Cancer    Graduation

Cancer Diagnosis During Medical School Offered Unique Insight into Patient Experience

Steve Haberkorn knows he’s not the first person to pursue a career in medicine out of a desire to help people. That’s why he did it, though – to help where he can and work to improve people’s lives.


Author Rachel Sauer | Publish Date May 15, 2023
Full Story

School of Medicine In the News

KKTV

Colorado doctors warning of skyrocketing alcohol use post-pandemic as liver transplants among younger people increase

news outletKKTV
Publish DateFebruary 14, 2024

Colorado doctors say they are concerned about alcohol use after the pandemic, as liver transplants among younger people increase.

More News
Neurology Live

The Evolving Landscape of Treatments for Multiple Sclerosis in 2024: Enrique Alvarez, MD, PhD

news outletNeurology Live
Publish DateFebruary 13, 2024

As the landscape of care evolves in multiple sclerosis (MS), clinicians continue their efforts in optimizing therapeutic approaches for patients. Investigating de-escalation of therapies, which involves transitioning patients from high or moderate efficacy disease-modifying therapies to lower efficacy ones to lower risk of adverse effects, has been a topic of interest.

More News
TCTMD

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

news outletTCTMD
Publish DateFebruary 13, 2024

Cumulative safety data from three trials testing the reversible direct factor XIa inhibitor asundexian in patients at risk for stroke or recurrent cardiovascular events suggest a better bleeding profile compared with apixaban (Eliquis; Bristol Myers Squibb) in a variety of patient types.

More News
CBS News

Flu, COVID, RSV: Colorado doctor says 5% of hospitalized patients have two viruses at the same time

news outletCBS News
Publish DateFebruary 13, 2024

Chances are you or someone you know has gotten sick over the past few weeks or months. 

More News